IP Library Granted Patent US 12,019,311
Granted Patent B2
US 12,019,311 · App. 17/089,233 · Granted Jun 25, 2024

Ophthalmic lens including a peripheral zone having an add-power offset and a spatially-modulated optical parameter

Inventors: Kristen Hovinga (Honeoye Falls, NY); Mohammad Musleh (Rochester, NY); Mengchen Xu (West Henrietta, NY)
Assignee: Bausch & Lomb Ireland Limited
G02C7/044G02C7/049
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,019,311
App. No.
17/089,233
Granted
Jun 25, 2024
Kind
B2
Abstract

An ophthalmic lens, comprising a central zone having at least a first power, and a peripheral zone having an add-power offset relative to the at least first power and a spatially-modulated optical parameter. In some embodiments, the central zone has a diameter in the range 2.0 to 5.0 mm. In some embodiments, the central zone is not more than 1 mm smaller than a wearer's pupil. The spatially-modulated optical parameter may include optical power, light scattering or light transmission.

Claims (19)

1. An ophthalmic lens, comprising: a central zone having at least a first power; and a peripheral zone disposed radially outward of the central zone, the peripheral zone having an add-power offset relative to the at least first power and a smoothly varying spatially-modulated optical power profile that extends in a radially outward direction from a location radially outward of central zone, the power profile having a plurality of maxima and a plurality of minima.

2. The lens of claim 1 , wherein the central zone has a diameter of at least 3 mm.

3. The lens of claim 1 , wherein the central zone is not more than 1 mm smaller than a wearer's pupil.

4. The lens of claim 1 , wherein the central zone has a diameter of at least 2.0 mm.

5. The lens of claim 1 , wherein the central zone has a diameter in the range 2.0 to 5.0 mm.

6. The lens of claim 5 , wherein the add power offset is in the range 0.5 diopters to 5 diopters.

7. The lens of claim 1 , further comprising a transition zone between the central zone and the peripheral zone such that a power profile from an optical axis of the lens to the outer diameter of the peripheral zone varies continuously.

8. The lens of claim 1 , wherein there is a step in power between the central zone and the peripheral zone.

9. The lens of claim 1 , wherein the maxima or the minima increase as a function of radial position.

10. The lens of claim 1 , wherein the maxima have a same dioptric value as one another and minima have a same dioptric value as one another.

11. The lens of claim 1 , wherein the add power offset is in the range 0.5 diopters to 5 diopters.

12. The lens of claim 11 , wherein the peripheral zone has a base power, and power differences between the base power and each of the maxima are in the range 0.05 diopters to 2 diopters.

13. The lens of claim 1 , wherein the lens is a contact lens.

14. The lens of claim 1 , wherein the central zone has a single power.

15. The lens of claim 12 , wherein the base power is uniform across the peripheral zone.

16. The lens of claim 12 , wherein the base power increases as a function of radial position across the peripheral zone.

17. The lens of claim 1 , wherein the lens is rotationally symmetric.

18. The lens of claim 1 , wherein the lens is a hydrogel contact lens packaged in combination with a buffered saline solution containing a pharmaceutical agent that reduces the progression of myopia.

19. The lens of claim 1 , wherein the add power offset comprises a step in power.

Assignments (11)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (066694/0131) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072460/0655 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 29, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 066707/0684 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 27, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066694/0131 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 057821/0800) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: TECHNOLAS PERFECT VISION GMBH; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061884/0514 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 055756/0281) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061777/0749 →
SECURITY INTEREST Recorded Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
SECURITY INTEREST Recorded Mar 29, 2021
From: BAUSCH+LOMB IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 055756/0281 →
SECURITY INTEREST Recorded Mar 29, 2021
From: BAUSCH+LOMB IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 055756/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2021
From: HOVINGA, KRISTEN; MUSLEH, MOHAMMAD; XU, MENGCHEN
To: BAUSCH & LOMB IRELAND LIMITED
Reel/Frame 055014/0718 →